Wed, Nov 26, 2014, 9:51 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

P L C SYSTEMS INC Message Board

  • i_hate_hillsamuel i_hate_hillsamuel Nov 15, 2010 9:42 AM Flag

    One console and 25 kits!

    Compared to 275 kits and 9 consoles last year. Well any questions about RG gaining traction and PLC's ability to build a business appear to be answered. My guess is that all the volume last year was to support studies, and no one is really using it. Tauscher commented that it was "uncharacteristically weak". Is he serious? He said they faced "challenging distractions" during the quarter. Perhaps if it's too challenging they should step down. They have been "working dilligently" to obtain financing. They have had several years, hired consultants, etc and have little to show for it. RG may be successful in someone elses hands, but this company is finished! We need sales and revenue, not IRS grants.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I think you're right about where the sales went, but that isn't unexpected or really negative. It's disappointing that the distributors in funny places (Bangladesh, Latvia [I have nothing against these places; I've had friends from both countries, but they aren't England, France and Germany]) haven't generated a few sales.

      The whole game is and always has been getting agreement that what RG does actually produces a worthwhile benefit. The background is that there have been at least two earlier "breakthroughs" against CIN that turned out to be illusory (both ineffective treatments, overnight hydration and NAC. Selling isn't one cath lab at a time (although I had hoped that some of that was going on) or one clinic at a time, it's one medical society at a time.

      Selling the company or the patents is exactly what you seem to be asking for: getting somebody else to manage RG. But so far, nobody seems to be willing to pay a reasonable price (I'd put that around $25MM, but opinions vary) for the patents.

      If the REMEDIAL study fully confirms MYTHOS, things ought to budge somewhere.

0.00890.0000(0.00%)Sep 24 3:49 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.